SecBot SecBot
8-K ·Filed Nov 10, 2026

ATRA

Atara Biotherapeutics, Inc.
NEUTRAL
Impact 5/10
Processed2h 52m ago SEC0001104659-26-125171
8-K Item 2.02: Earnings release

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-125171
Document: tmb-20261110x8k.htm0001104659-26-125171
Document: 0001104659-26-125171-index-headers.html0001104659-26-125171
Document: 0001104659-26-125171-index.html0001104659-26-125171
Document: 0001104659-26-125171.txt0001104659-26-125171
8-K Data (Synthetic)0001104659-26-125171

US Market Status

Market Closed · Opens Thu (14h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026

Fresh ATRA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access